Firefly Neuroscience, Inc.
AIFF
$4.25
$0.7922.83%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Revenue | 33.00K | 10.00K | 12.00K | 19.00K | 23.00K |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 33.00K | 10.00K | 12.00K | 19.00K | 23.00K |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | 33.00K | 10.00K | 12.00K | 19.00K | 23.00K |
SG&A Expenses | 3.42M | 919.00K | 814.00K | 1.56M | 278.00K |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 4.30M | 1.27M | 1.10M | 1.59M | 670.00K |
Operating Income | -4.27M | -1.26M | -1.09M | -1.57M | -647.00K |
Income Before Tax | -4.29M | -1.26M | -1.12M | -1.08M | -650.00K |
Income Tax Expenses | -- | -- | -- | 1.00K | -- |
Earnings from Continuing Operations | -4.29M | -1.26M | -1.12M | -1.08M | -650.00K |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -4.29M | -1.26M | -1.12M | -1.08M | -650.00K |
EBIT | -4.27M | -1.26M | -1.09M | -1.57M | -647.00K |
EBITDA | -4.26M | -1.26M | -- | -1.56M | -643.50K |
EPS Basic | -0.61 | -0.03 | -0.02 | -0.03 | -0.18 |
Normalized Basic EPS | -0.38 | -0.02 | -0.01 | -0.02 | -0.11 |
EPS Diluted | -0.61 | -0.03 | -0.02 | -0.03 | -0.18 |
Normalized Diluted EPS | -0.38 | -0.02 | -0.01 | -0.02 | -0.11 |
Average Basic Shares Outstanding | 7.08M | 49.95M | 49.95M | 35.42M | 3.68M |
Average Diluted Shares Outstanding | 7.08M | 49.95M | 49.95M | 35.42M | 3.68M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |